Physician profile
David B Owens
NPI 1588607618
$1,008.08
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $548 · 2020: $154 · 2022: $306.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $306.47 | 2022 | |
| Abbvie INC. | $213.53 | 2019-2020 | |
| Daiichi Sankyo INC. | $173.69 | 2019 | |
| Olympus America INC. | $36.27 | 2019 | |
| Merck Sharp & Dohme LLC | $36.08 | 2019-2020 | |
| Therapeuticsmd, INC. | $35.88 | 2019-2020 | |
| Allergan, INC. | $33.35 | 2019-2020 | |
| Ascend Therapeutics US, LLC | $33.00 | 2019 | |
| Novo Nordisk INC | $32.50 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.59 | 2020 | |
| Aesculap, INC. | $18.22 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $15.35 | 2019 | |
| Lilly USA, LLC | $15.04 | 2020 | |
| Covidien LP | $12.93 | 2020 | |
| Hologic Sales and Service, LLC | $12.58 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $11.60 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Owens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.